{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:13Z","timestamp":1791908353873,"version":"4.3.4"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bernese Lugenliga"},{"name":"Swiss Lugenliga"},{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Idiopathic pulmonary fibrosis (IPF) is characterized by permanent scarring of lung tissue and declining lung function, and is an incurable disease with increase in prevalence over the past decade. The current consensus is that aberrant wound healing following repeated injuries to the pulmonary epithelium is the most probable cause of IPF, with various immune inflammatory pathways having been reported to impact disease pathogenesis. While the role of immune cells, specifically T lymphocytes and regulatory T cells (Treg), in IPF pathogenesis has been reported and discussed recently, the pathogenic or beneficial roles of these cells in inducing or preventing lung fibrosis is still debated. This lack of understanding could be due in part to the difficulty in obtaining diseased human lung tissue for research purposes. For this reason, many animal models have been developed over the years to attempt to mimic the main clinical hallmarks of IPF: among these, inducing lung injury in rodents with the anti-cancer agent bleomycin has now become the most commonly studied animal model of IPF. Pulmonary fibrosis is the major side effect when bleomycin is administered for cancer treatment in human patients, and a similar effect can be observed after intra-tracheal administration of bleomycin to rodents. Despite many pathophysiological pathways of lung fibrosis having been investigated in bleomycin-injured animal models, one central facet still remains controversial, namely the involvement of specific T lymphocyte subsets, and in particular Treg, in disease pathogenesis. This review aims to summarize the major findings and conclusions regarding the involvement of immune cells and their receptors in the pathogenesis of IPF, and to elaborate on important parallels between animal models and the human disease. A more detailed understanding of the role of Treg and other immune cell subsets in lung injury and fibrosis derived from animal models is a critical basis for translating this knowledge to the development of new immune-based therapies for the treatment of human IPF.<\/jats:p>","DOI":"10.1007\/s10238-022-00945-7","type":"journal-article","created":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T15:02:32Z","timestamp":1668956552000},"page":"1075-1088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models"],"prefix":"10.1007","volume":"23","author":[{"given":"Mutlu","family":"Seyran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scalise","family":"Melanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stumbles","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazdhar","family":"Amiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blank","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,20]]},"reference":[{"key":"945_CR1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1183\/09031936.00069307","volume":"30","author":"TM Maher","year":"2007","unstructured":"Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: Multiple causes and multiple mechanisms? Eur Respir J. 2007;30:835\u20139.","journal-title":"Eur Respir J"},{"key":"945_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm7080201","volume":"7","author":"S Barratt","year":"2018","unstructured":"Barratt S, Creamer A, Hayton C, Chaudhuri N. Idiopathic pulmonary fibrosis (IPF): an overview. J Clin Med. 2018;7:201.","journal-title":"J Clin Med"},{"key":"945_CR3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.12688\/f1000research.8209.1","volume":"5","author":"C Daccord","year":"2016","unstructured":"Daccord C, Maher TM. Recent advances in understanding idiopathic pulmonary fibrosis. F1000Research. 2016;5:1046.","journal-title":"F1000Research"},{"key":"945_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01902148.2014.979516","volume":"41","author":"JD Williamson","year":"2015","unstructured":"Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res. 2015;41:57\u201373.","journal-title":"Exp Lung Res"},{"key":"945_CR5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2002.00220.x","author":"G Izbicki","year":"2002","unstructured":"Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002. https:\/\/doi.org\/10.1046\/j.1365-2613.2002.00220.x.","journal-title":"Int J Exp Pathol"},{"key":"945_CR6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.120.2.617","volume":"120","author":"S Sleijfer","year":"2001","unstructured":"Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617\u201324.","journal-title":"Chest"},{"key":"945_CR7","first-page":"251","volume":"117","author":"M Gharaee-Kermani","year":"2005","unstructured":"Gharaee-Kermani M, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis. Methods Mol Med. 2005;117:251\u20139.","journal-title":"Methods Mol Med"},{"key":"945_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol\u2014Lung Cellular Mol Physiol. 2008;294:152\u201360.","journal-title":"Am J Physiol\u2014Lung Cellular Mol Physiol"},{"key":"945_CR9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","volume":"4","author":"J Tashiro","year":"2017","unstructured":"Tashiro J, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med. 2017;4:118.","journal-title":"Front Med"},{"key":"945_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.0512261","volume":"93","author":"S Lo Re","year":"2013","unstructured":"Lo Re S, Lison D, Huaux F. CD4 + T lymphocytes in Lung fibrosis: diverse subsets, diverse functions. J Leukoc Biol. 2013;93:499\u2013510.","journal-title":"J Leukoc Biol"},{"key":"945_CR11","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.1203476","volume":"191","author":"J Xue","year":"2013","unstructured":"Xue J, et al. Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients. J Immunol. 2013;191:2089\u201395.","journal-title":"J Immunol"},{"key":"945_CR12","first-page":"544","volume":"41","author":"YY Zhao","year":"2018","unstructured":"Zhao YY, et al. The role of B cell activating factor in the differential diagnosis of usual interstitial pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:544\u201350.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"945_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.0707504","volume":"83","author":"IG Luzina","year":"2007","unstructured":"Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol. 2007;83:237\u201344.","journal-title":"J Leukoc Biol"},{"key":"945_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1183\/09031936.95.08020266","volume":"8","author":"A Wells","year":"1995","unstructured":"Wells A, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J. 1995;8:266\u201371.","journal-title":"Eur Respir J"},{"key":"945_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000097133","volume":"74","author":"ER Parra","year":"2007","unstructured":"Parra ER, et al. Clinical investigations inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration. 2007;74:159\u201369.","journal-title":"Respiration"},{"key":"945_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","volume":"5","author":"O Desai","year":"2018","unstructured":"Desai O, Winkler J, Minasyan M, Herzog EL. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front Med. 2018;5:43.","journal-title":"Front Med"},{"key":"945_CR17","first-page":"1489","volume":"8","author":"EM Lowery","year":"2013","unstructured":"Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ. Clinical interventions in aging dovepress the aging lung. Clin Interv Aging. 2013;8:1489\u201396.","journal-title":"Clin Interv Aging"},{"key":"945_CR18","first-page":"3","volume":"25","author":"EJ Kovacs","year":"2002","unstructured":"Kovacs EJ, Grabowski KA, Duffner LA, Plackett TP, Gregory MS. Survival and cell mediated immunity after burn injury in aged mice. J Am Aging Assoc. 2002;25:3.","journal-title":"J Am Aging Assoc"},{"key":"945_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-2-287-93911-2_4","author":"C Trivalle","year":"2009","unstructured":"Trivalle C, Maurel S, Taillandier J, Rudant E, Bonhomme-Faivre L. Valeur pronostique \u00e0 2 ans de l\u2019interleukine-6 dans une population de sujets \u00e2g\u00e9s fragiles. La Pers \u00c2g\u00e9e Fragile. 2009. https:\/\/doi.org\/10.1007\/978-2-287-93911-2_4.","journal-title":"La Pers \u00c2g\u00e9e Fragile"},{"key":"945_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","volume":"51","author":"WB Ershler","year":"2000","unstructured":"Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245\u201370.","journal-title":"Annu Rev Med"},{"key":"945_CR21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.cell.2021.03.005","volume":"184","author":"JL Schneider","year":"2021","unstructured":"Schneider JL, et al. The aging lung: physiology, disease, and immunity. Cell. 2021;184:1990.","journal-title":"Cell"},{"key":"945_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.it.2009.05.004","volume":"30","author":"A Panda","year":"2009","unstructured":"Panda A, et al. Human innate Immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009;30:325.","journal-title":"Trends Immunol"},{"key":"945_CR23","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1172\/JCI59777","volume":"121","author":"J Zhao","year":"2011","unstructured":"Zhao J, Zhao J, Legge K, Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest. 2011;121:4921\u201330.","journal-title":"J Clin Invest"},{"key":"945_CR24","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1158\/0008-5472.CAN-07-5769","volume":"68","author":"A Grolleau-Julius","year":"2008","unstructured":"Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL. Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res. 2008;68:6341\u20139.","journal-title":"Cancer Res"},{"key":"945_CR25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000199451","volume":"55","author":"M Provinciali","year":"2009","unstructured":"Provinciali M, Moresi R, Donnini A, Lisa RM. Reference values for CD4+ and CD8+ T lymphocytes with na\u00efve or memory phenotype and their association with mortality in the elderly. Gerontology. 2009;55:314\u201321.","journal-title":"Gerontology"},{"key":"945_CR26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1474-9726.2011.00730.x","volume":"10","author":"N Mirza","year":"2011","unstructured":"Mirza N, Pollock K, Hoelzinger DB, Dominguez AL, Lustgarten J. Comparative kinetic analyses of gene profiles of na\u00efve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterations. Aging Cell. 2011;10:853.","journal-title":"Aging Cell"},{"key":"945_CR27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000355303","volume":"60","author":"A Jagger","year":"2014","unstructured":"Jagger A, Shimojima Y, Goronzy JJ, Weyand CM. T regulatory cells and the immune aging process. Gerontology. 2014;60:130.","journal-title":"Gerontology"},{"key":"945_CR28","first-page":"1835","volume":"181","author":"C Chougnet Huang","year":"2008","unstructured":"Chougnet Huang C, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. Am Assoc Immnol. 2008;181:1835\u201348.","journal-title":"Am Assoc Immnol"},{"key":"945_CR29","first-page":"540","volume":"140","author":"R Gregg","year":"2005","unstructured":"Gregg R, et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. academic.oup.com. 2005;140:540\u20136.","journal-title":"academic.oup.com"},{"key":"945_CR30","doi-asserted-by":"crossref","unstructured":"Chiu BC, Stolberg VR, Zhang H, Chensue SW (2007) Increased Foxp3+ Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice. Elsevier","DOI":"10.1016\/j.mad.2007.09.002"},{"key":"945_CR31","doi-asserted-by":"publisher","unstructured":"Sharma S, Dominguez AL, Lustgarten J (2006) undefined. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. Am Assoc Immnol.https:\/\/doi.org\/10.4049\/jimmunol.177.12.8348","DOI":"10.4049\/jimmunol.177.12.8348"},{"issue":"6","key":"945_CR32","doi-asserted-by":"crossref","first-page":"e141690","DOI":"10.1172\/jci.insight.141690","volume":"6","author":"L Morales-Nebreda","year":"2021","unstructured":"Morales-Nebreda L, et al. Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia. JCI Insight 2021;6(6):e141690.","journal-title":"JCI Insight"},{"key":"945_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/febs.15743","volume":"289","author":"B Deng","year":"2022","unstructured":"Deng B, et al. FOXP3+ regulatory T cells and age-related diseases. FEBS J. 2022;289:319\u201335.","journal-title":"FEBS J"},{"key":"945_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","volume":"259","author":"DV Sawant","year":"2014","unstructured":"Sawant DV, Vignali DAA. Once a Treg, always a Treg? Immunol Rev. 2014;259:173\u201391.","journal-title":"Immunol Rev"},{"key":"945_CR35","first-page":"986","volume":"198","author":"JD Fontenot","year":"2017","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. J Immunol. 2017;198:986\u201392.","journal-title":"J Immunol"},{"key":"945_CR36","first-page":"981","volume":"198","author":"S Hori","year":"2017","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. J Immunol. 2017;198:981\u20135.","journal-title":"J Immunol"},{"key":"945_CR37","doi-asserted-by":"crossref","first-page":"1800063","DOI":"10.1002\/bies.201800063","volume":"40","author":"M Liu","year":"2018","unstructured":"Liu M, Li S, Li MO. TGF-\u03b2 control of adaptive immune tolerance: a break from Treg cells. BioEssays. 2018;40:1800063.","journal-title":"BioEssays"},{"key":"945_CR38","first-page":"51","volume":"3","author":"A Schmidt","year":"2012","unstructured":"Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of treg-mediated t cell suppression. Front Immunol. 2012;3:51.","journal-title":"Front Immunol"},{"key":"945_CR39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry A, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011;34:566\u201378.","journal-title":"Immunity"},{"key":"945_CR40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhang S. T Cells in fibrosis and fibrotic diseases. Front Immunol. 2020;11:1142.","journal-title":"Front Immunol"},{"key":"945_CR41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/rccm.200812-1936OC","volume":"179","author":"I Kotsianidis","year":"2009","unstructured":"Kotsianidis I, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:1121\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"945_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fimmu.2016.00334","volume":"7","author":"HC Jeffery","year":"2016","unstructured":"Jeffery HC, Braitch MK, Brown S, Oo YH. Clinical potential of regulatory T cell therapy in liver diseases: an overview and current perspectives. Front Immunol. 2016;7:334.","journal-title":"Front Immunol"},{"key":"945_CR43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-1536-3-18","volume":"3","author":"G Trujillo","year":"2010","unstructured":"Trujillo G, Hartigan AJ, Hogaboam CM. T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-\/- mice. Fibrogenesis Tissue Repair. 2010;3:18.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"945_CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cytogfr.2013.03.001","volume":"24","author":"I Comerford","year":"2013","unstructured":"Comerford I, et al. A myriad of functions and complex regulation of the CCR7\/CCL19\/CCL21 chemokine axis in the adaptive immune system. Cytokine Growth Factor Rev. 2013;24:269\u201383.","journal-title":"Cytokine Growth Factor Rev"},{"key":"945_CR45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jcp.2005.026872","volume":"59","author":"ES Choi","year":"2006","unstructured":"Choi ES, et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J Clin Pathol. 2006;59:28\u201339.","journal-title":"J Clin Pathol"},{"key":"945_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-2112-7","volume":"22","author":"H Takei","year":"2020","unstructured":"Takei H, Yasuoka H, Yoshimoto K, Takeuchi T. Aryl hydrocarbon receptor signals attenuate lung fibrosis in the bleomycin-induced mouse model for pulmonary fibrosis through increase of regulatory T cells. Arthritis Res Ther. 2020;22:1\u201310.","journal-title":"Arthritis Res Ther"},{"key":"945_CR47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Meglio PD, Gialitakis M, Duarte JH. The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol. 2014;32:403\u201332.","journal-title":"Annu Rev Immunol"},{"key":"945_CR48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65\u201371.","journal-title":"Nature"},{"key":"945_CR49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/tx7001965","volume":"21","author":"LP Nguyen","year":"2008","unstructured":"Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol. 2008;21:102\u201316.","journal-title":"Chem Res Toxicol"},{"key":"945_CR50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1165\/rcmb.2013-0423OC","volume":"51","author":"YJ Tang","year":"2014","unstructured":"Tang YJ, et al. Latent transforming growth factor-\u03b21 protects against bleomycin-induced lung injury in mice. Am J Respir Cell Mol Biol. 2014;51:761\u201371.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou L, et al. TGF-\u0392-induced Foxp3 inhibits TH17 cell differentiation by antagonizing ROR\u03b3t function. Nature. 2008;453:236\u201340.","journal-title":"Nature"},{"key":"945_CR52","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12715","volume":"88","author":"L Wang","year":"2018","unstructured":"Wang L, et al. Recovery from acute lung injury can be regulated via modulation of regulatory T cells and Th17 cells. Scand J Immunol. 2018;88: e12715.","journal-title":"Scand J Immunol"},{"key":"945_CR53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","volume":"218","author":"D Boveda-Ruiz","year":"2013","unstructured":"Boveda-Ruiz D, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology. 2013;218:245\u201354.","journal-title":"Immunobiology"},{"key":"945_CR54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tice.2018.06.003","volume":"53","author":"K Chakraborty","year":"2018","unstructured":"Chakraborty K, Chatterjee S, Bhattacharyya A. Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis. Tissue Cell. 2018;53:87\u201392.","journal-title":"Tissue Cell"},{"key":"945_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.03.020","author":"SZ Birjandi","year":"2016","unstructured":"Birjandi SZ, et al. CD4+CD25hiFoxp3+ cells exacerbate bleomycin-induced pulmonary fibrosis. Am J Pathol. 2016. https:\/\/doi.org\/10.1016\/j.ajpath.2016.03.020.","journal-title":"Am J Pathol"},{"key":"945_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt535","volume":"6","author":"JL Tan","year":"2015","unstructured":"Tan JL, et al. Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response. Stem Cell Res Ther. 2015;6:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"945_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0783-2","volume":"19","author":"K Kamio","year":"2018","unstructured":"Kamio K, et al. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation. Respir Res. 2018;19:1\u201314.","journal-title":"Respir Res"},{"key":"945_CR58","volume":"386","author":"JH Zhang","year":"2020","unstructured":"Zhang JH, Deng JH, Yao XL, Wang JL, Xiao JH. CD4+CD25+ Tregs as dependent factor in the course of bleomycin-induced pulmonary fibrosis in mice. Exp Cell Res. 2020;386: 111700.","journal-title":"Exp Cell Res"},{"key":"945_CR59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1165\/rcmb.2003-0029OC","volume":"29","author":"MP Chung","year":"2003","unstructured":"Chung MP, et al. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol. 2003;29:375\u201380.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cbin.10410","volume":"39","author":"L Lei","year":"2015","unstructured":"Lei L, Zhong XN, He ZY, Zhao C, Sun XJ. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice. Cell Biol Int. 2015;39:388\u201399.","journal-title":"Cell Biol Int"},{"key":"945_CR61","first-page":"14","volume":"34","author":"L Lei","year":"2016","unstructured":"Lei L, et al. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol. 2016;34:14\u201322.","journal-title":"Clin Exp Rheumatol"},{"key":"945_CR62","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/pats.200601-003TK","volume":"3","author":"M Selman","year":"2006","unstructured":"Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers. Proc Am Thorac Soc. 2006;3:364\u201372.","journal-title":"Proc Am Thorac Soc"},{"key":"945_CR63","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/cei.12802","volume":"185","author":"S Segawa","year":"2016","unstructured":"Segawa S, et al. The regulatory role of interferon-\u03b3 producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis. Clin Exp Immunol. 2016;185:348\u201360.","journal-title":"Clin Exp Immunol"},{"key":"945_CR64","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-12-131","volume":"12","author":"K Yamauchi","year":"2011","unstructured":"Yamauchi K, et al. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res. 2011;12:131.","journal-title":"Respir Res"},{"key":"945_CR65","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","volume":"177","author":"E Lockhart","year":"2006","unstructured":"Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by \u03b3\u03b4 T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006;177:4662\u20139.","journal-title":"J Immunol"},{"key":"945_CR66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10753-008-9062-6","volume":"31","author":"RK Braun","year":"2008","unstructured":"Braun RK, et al. IL-17 producing \u03b3\u03b4 T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation. 2008;31:167\u201379.","journal-title":"Inflammation"},{"key":"945_CR67","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ajpath.2010.11.055","volume":"178","author":"DA Pociask","year":"2011","unstructured":"Pociask DA, et al. \u03b3\u03b4 T cells attenuate bleomycin-induced fibrosis through the production of CXCL10. Am J Pathol. 2011;178:1167\u201376.","journal-title":"Am J Pathol"},{"key":"945_CR68","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1152\/ajplung.00122.2011","volume":"301","author":"EF Redente","year":"2011","unstructured":"Redente EF, et al. Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. Am J Physiol\u2014Lung Cell Mol Physiol. 2011;301:510\u20138.","journal-title":"Am J Physiol\u2014Lung Cell Mol Physiol"},{"key":"945_CR69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson MS, et al. Bleomycin and IL-1\u03b2-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med. 2010;207:535\u201352.","journal-title":"J Exp Med"},{"key":"945_CR70","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.1600465","volume":"198","author":"J Lv","year":"2017","unstructured":"Lv J, et al. BLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4 + T Cells. J Immunol. 2017;198:1673\u201384.","journal-title":"J Immunol"},{"key":"945_CR71","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.4049\/jimmunol.177.5.3439","volume":"177","author":"KA Lundeen","year":"2006","unstructured":"Lundeen KA, Sun B, Karlsson L, Fourie AM. Leukotriene B 4 receptors BLT1 and BLT2: expression and function in human and murine mast cells. J Immunol. 2006;177:3439\u201347.","journal-title":"J Immunol"},{"key":"945_CR72","doi-asserted-by":"crossref","first-page":"104857","DOI":"10.1016\/j.phrs.2020.104857","volume":"158","author":"R He","year":"2020","unstructured":"He R, Chen Y, Cai Q. The role of the LTB4-BLT1 axis in health and disease. Pharmacol Res. 2020;158:104857.","journal-title":"Pharmacol Res"},{"key":"945_CR73","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2016-208423","volume":"72","author":"K Milger","year":"2017","unstructured":"Milger K, et al. Pulmonary CCR2+ CD4+ T cells are immune regulatory and attenuate lung fibrosis development. Thorax. 2017;72:1007\u201320.","journal-title":"Thorax"},{"key":"945_CR74","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994;91:3652\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"945_CR75","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/eji.200738120","volume":"38","author":"Y Belkaid","year":"2008","unstructured":"Belkaid Y. Role of Foxp3-positive regulatory T cells during infection. Eur J Immunol. 2008;38:918\u201321.","journal-title":"Eur J Immunol"},{"key":"945_CR76","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.micinf.2009.04.002","volume":"11","author":"SF Ziegler","year":"2009","unstructured":"Ziegler SF, Buckner JH. FOXP3 and the regulation of Treg\/Th17 differentiation. Microbes Infect. 2009;11:594\u20138.","journal-title":"Microbes Infect"},{"key":"945_CR77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.200609-1279OC","volume":"176","author":"CP Baran","year":"2007","unstructured":"Baran CP, et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:78\u201389.","journal-title":"Am J Respir Crit Care Med"},{"key":"945_CR78","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1164\/rccm.200712-1827OC","volume":"179","author":"PF Mercer","year":"2009","unstructured":"Mercer PF, et al. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary Fibrosis. Am J Respir Crit Care Med. 2009;179:414\u201325.","journal-title":"Am J Respir Crit Care Med"},{"key":"945_CR79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1152\/ajplung.00006.2006","volume":"291","author":"J Xu","year":"2006","unstructured":"Xu J, Mora AL, LaVoy J, Brigham KL, Rojas M. Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet. Am J Physiol\u2014Lung Cell Mol Physiol. 2006;291:658\u201367.","journal-title":"Am J Physiol\u2014Lung Cell Mol Physiol"},{"key":"945_CR80","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1073\/pnas.261570598","volume":"98","author":"AA Lighvani","year":"2001","unstructured":"Lighvani AA, et al. T-bet is rapidly induced by interferon-\u03b3 in lymphoid and myeloid cells. Proc Natl Acad Sci USA. 2001;98:15137\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"945_CR81","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.1000749","volume":"185","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, et al. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol. 2010;185:3174\u201383.","journal-title":"J Immunol"},{"key":"945_CR82","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo SJ, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655\u201369.","journal-title":"Cell"},{"key":"945_CR83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/ajplung.00122.2010","volume":"300","author":"L Sun","year":"2011","unstructured":"Sun L, et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2\/CCR2 axis. Am J Physiol\u2014Lung Cell Mol Physiol. 2011;300:341\u201353.","journal-title":"Am J Physiol\u2014Lung Cell Mol Physiol"},{"key":"945_CR84","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT. The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7:827\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"945_CR85","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3389\/fimmu.2018.02432","volume":"9","author":"OS Kotsiou","year":"2018","unstructured":"Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33\/ST2 axis in organ fibrosis. Front Immunol. 2018;9:2432.","journal-title":"Front Immunol"},{"key":"945_CR86","volume":"4","author":"Q Liu","year":"2019","unstructured":"Liu Q, et al. IL-33\u2013mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury. JCI Insight. 2019;4:e123919.","journal-title":"JCI Insight"},{"key":"945_CR87","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676\u201389.","journal-title":"Nat Rev Immunol"},{"key":"945_CR88","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1165\/rcmb.2013-0093OC","volume":"49","author":"IG Luzina","year":"2013","unstructured":"Luzina IG, et al. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 2013;49:999\u20131008.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.170.3.655","volume":"170","author":"PF Piguet","year":"1989","unstructured":"Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989;170:655\u201363.","journal-title":"J Exp Med"},{"key":"945_CR90","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3109\/01902149809099592","volume":"24","author":"LA Ortiz","year":"1998","unstructured":"Ortiz LA, et al. Expression of the TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res. 1998;24:721\u201343.","journal-title":"Exp Lung Res"},{"key":"945_CR91","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","volume":"38","author":"F Saito","year":"2008","unstructured":"Saito F, et al. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol. 2008;38:566\u201371.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR92","doi-asserted-by":"crossref","first-page":"7947596","DOI":"10.1155\/2019\/7947596","volume":"2019","author":"JM Shieh","year":"2019","unstructured":"Shieh JM, Tseng HY, Jung F, Yang SH, Lin JC. Elevation of IL-6 and IL-33 levels in serum associated with lung fibrosis and skeletal muscle wasting in a bleomycin-induced lung injury mouse model. Mediat Inflamm. 2019;2019:7947596.","journal-title":"Mediat Inflamm"},{"key":"945_CR93","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI11963","volume":"107","author":"JF Pittet","year":"2001","unstructured":"Pittet JF, et al. TGF-\u03b2 is a critical mediator of acute lung injury. J Clin Invest. 2001;107:1537\u201344.","journal-title":"J Clin Invest"},{"key":"945_CR94","doi-asserted-by":"crossref","unstructured":"Liu T, DeLosSantos FG, Phan SH. The bleomycin model of pulmonary fibrosis. In: Methods in molecular biology, vol 1627. Humana Press Inc.; 2017. pp. 27\u201342.","DOI":"10.1007\/978-1-4939-7113-8_2"},{"key":"945_CR95","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/arrd.1983.127.1.63","volume":"127","author":"DJ Schrier","year":"1983","unstructured":"Schrier DJ, Kunkel RG, Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis. 1983;127:63\u20136.","journal-title":"Am Rev Respir Dis"},{"key":"945_CR96","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328349ac2b","author":"MA Mouratis","year":"2011","unstructured":"Mouratis MA, Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med. 2011. https:\/\/doi.org\/10.1097\/MCP.0b013e328349ac2b.","journal-title":"Curr Opin Pulm Med"},{"key":"945_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0621-y","volume":"18","author":"M Kreuter","year":"2017","unstructured":"Kreuter M, et al. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir Res. 2017;18:1\u201310.","journal-title":"Respir Res"},{"key":"945_CR98","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/gerona\/glp040","volume":"64A","author":"J Xu","year":"2009","unstructured":"Xu J, et al. Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J Gerontol Ser A. 2009;64A:731\u20139.","journal-title":"J Gerontol Ser A"},{"key":"945_CR99","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.trsl.2015.09.004","volume":"166","author":"J Tashiro","year":"2015","unstructured":"Tashiro J, et al. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Transl Res. 2015;166:554\u201367.","journal-title":"Transl Res"},{"key":"945_CR100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1165\/rcmb.2007-0340OC","volume":"39","author":"JW Voltz","year":"2008","unstructured":"Voltz JW, et al. Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008;39:45\u201352.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR101","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0002-9440(10)62470-4","volume":"166","author":"M Gharaee-Kermani","year":"2005","unstructured":"Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH. Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2005;166:1593\u2013606.","journal-title":"Am J Pathol"},{"key":"945_CR102","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2613.2002.00220.x","volume":"83","author":"G Izbicki","year":"2002","unstructured":"Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83:111\u20139.","journal-title":"Int J Exp Pathol"},{"key":"945_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-016-0492-7","volume":"18","author":"Z Hou","year":"2017","unstructured":"Hou Z, et al. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis. Respir Res. 2017;18:1\u20139.","journal-title":"Respir Res"},{"key":"945_CR104","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.201206-1109OC","volume":"187","author":"RA Reilkoff","year":"2013","unstructured":"Reilkoff RA, et al. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-\u03b21-induced pulmonary fibrosis. Am J Respir Crit Care Med. 2013;187:180\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"945_CR105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","volume":"241","author":"G Cheng","year":"2011","unstructured":"Cheng G, Yu A, Malek TR. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev. 2011;241:63\u201376.","journal-title":"Immunol Rev"},{"key":"945_CR106","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.imbio.2008.07.026","volume":"213","author":"J Driesen","year":"2008","unstructured":"Driesen J, Popov A, Schultze JL. CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology. 2008;213:849\u201358.","journal-title":"Immunobiology"},{"key":"945_CR107","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.4049\/jimmunol.175.3.1566","volume":"175","author":"D Herndler-Brandstetter","year":"2005","unstructured":"Herndler-Brandstetter D, et al. CD25-Expressing CD8 + T cells are potent memory cells in old age. J Immunol. 2005;175:1566\u201374.","journal-title":"J Immunol"},{"key":"945_CR108","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.1200109","volume":"188","author":"D Liang","year":"2012","unstructured":"Liang D, et al. Role of CD25 + dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis. J Immunol. 2012;188:5785\u201391.","journal-title":"J Immunol"},{"key":"945_CR109","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00344.2017","volume":"314","author":"SJ Gurczynski","year":"2018","unstructured":"Gurczynski SJ, Moore BB. IL-17 in the lung: the good, the bad, and the ugly. Am J Physiol\u2014Lung Cell Mol Physiol. 2018;314:L6\u201316.","journal-title":"Am J Physiol\u2014Lung Cell Mol Physiol"},{"key":"945_CR110","doi-asserted-by":"crossref","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","volume":"316","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2019;316:L487\u201397.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"945_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep28261","volume":"6","author":"JZ Kechagia","year":"2016","unstructured":"Kechagia JZ, Ezra DG, Burton MJ, Bailly M. Fibroblasts profiling in scarring trachoma identifies IL-6 as a functional component of a fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop. Sci Rep. 2016;6:1\u201311.","journal-title":"Sci Rep"},{"key":"945_CR112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.5092","volume":"245","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, De Los Santos FG, Wu Z, Liu T, Phan SH. An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis. J Pathol. 2018;245:399\u2013409.","journal-title":"J Pathol"},{"key":"945_CR113","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, et al. TGF-\u03b2 induces ST2 and programs ILC2 development. Nat Commun. 2020;11:35.","journal-title":"Nat Commun"},{"key":"945_CR114","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","volume":"111","author":"E Hams","year":"2014","unstructured":"Hams E, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA. 2014;111:367\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"945_CR115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41590-021-01097-8","volume":"232","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat Immunol. 2022;232(23):237\u201350.","journal-title":"Nat Immunol"},{"issue":"3","key":"945_CR116","doi-asserted-by":"crossref","first-page":"2000018","DOI":"10.1183\/13993003.00018-2020","volume":"57","author":"Y Nakatsuka","year":"2021","unstructured":"Nakatsuka Y, et al. Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1. Eur Respir J. 2021;57(3):2000018.","journal-title":"Eur Respir J"},{"issue":"3","key":"945_CR117","doi-asserted-by":"crossref","first-page":"2004029","DOI":"10.1183\/13993003.04029-2020","volume":"57","author":"A Froidure","year":"2021","unstructured":"Froidure A, Crestani B. Regulation of immune cells in lung fibrosis: the reign of regnase-1? Eur Respir J. 2021;57(3):2004029.","journal-title":"Eur Respir J"},{"key":"945_CR118","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4049\/jimmunol.1402534","volume":"194","author":"N Krishnamoorthy","year":"2015","unstructured":"Krishnamoorthy N, et al. Cutting edge: Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2015;194:863\u20137.","journal-title":"J Immunol"},{"key":"945_CR119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.02.006","volume":"59","author":"SB Wallach-Dayan","year":"2015","unstructured":"Wallach-Dayan SB, et al. Cutting edge: FasL+ immune cells promote resolution of fibrosis. J Autoimmun. 2015;59:67\u201376.","journal-title":"J Autoimmun"},{"key":"945_CR120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1440-1843.2002.00369.x","volume":"7","author":"K Kuwano","year":"2002","unstructured":"Kuwano K, et al. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases. Respirology. 2002;7:15\u201321.","journal-title":"Respirology"},{"key":"945_CR121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1165\/rcmb.2012-0198OC","volume":"48","author":"BT Garibaldi","year":"2013","unstructured":"Garibaldi BT, et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol. 2013;48:35\u201343.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"945_CR122","doi-asserted-by":"crossref","unstructured":"Peng X, et al. CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-\u00df1 exposed murine lung. Front Pharmacol 2014;5","DOI":"10.3389\/fphar.2014.00080"},{"key":"945_CR123","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2016.06.002","volume":"186","author":"MW Moore","year":"2016","unstructured":"Moore MW, Herzog EL. Regulatory T cells in idiopathic pulmonary fibrosis: Too much of a good thing? Am J Pathol. 2016;186:1978\u201381.","journal-title":"Am J Pathol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00945-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T14:21:32Z","timestamp":1690813292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00945-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,20]]},"references-count":123,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00945-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,20]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}